Tetratherix is pleased to announce the appointment of Will Knox to the role of Chief Executive Officer (CEO) effective immediately. Will brings to Tetratherix 20 years of strong leadership and entrepreneurial experience, having worked on the development and commercialisation of medical technologies for multiple as well as early-stage developers and investors.